Jared Fischer, Ph.D. (OHSU)
February 14, 2025
Knight Cancer Institute research of pancreatic cancer
February 14, 2025
Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer researchers at OHSU, have developed PAC-MANN, a test that uses a small blood sample to detect changes in protease activity, a key indicator of the most common and deadliest form of pancreatic cancer. (OHSU/Christine Torres Hicks)
Knight Cancer Institute research of pancreatic cancer
February 14, 2025
Top left, Rosalie Sears, Ph.D., Ben Kingston, Ph.D., Megan Sousa, and Sadik Esner, Ph.D., with Jared Fischer, Ph.D., sitting left; and Jose Luis Montoya Mira, Ph.D. (OHSU/Christine Torres Hicks)
El estudio ofrece nuevos conocimientos acerca del desarrollo de la audición en niños
February 13, 2025
Una investigación de OHSU examina el ‘efecto de fiesta cóctel’; podría llevar a intervenciones eficaces que mejoren el aprendizaje, desarrollo.
Study provides new insight on hearing development in children
February 13, 2025
OHSU research examines ‘cocktail party effect’; could lead to effective interventions that improve learning, development.
Científicos de OHSU desarrollan el primer modelo transgénico para la investigacion de la hepatitis B
February 12, 2025
El modelo animal genéticamente modificado podría llevar a nuevos tratamientos para la enfermedad global.
OHSU scientists develop first transgenic model for hepatitis B research
February 12, 2025
The genetically modified animal model could lead to new treatments for the global disease.
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
February 12, 2025
Called PAC-MANN, the test developed at OHSU could help save lives.
Prueba de sangre nueva identifica cáncer pancreático difícil de detectar con 85% de precisión
February 12, 2025
Llamada PAC-MANN, la prueba desarrollada en OHSU puede ayudar a salvar vidas.
James Frank research at OHSU
February 12, 2025
James Frank, Ph.D., will use new Avenir Award funding from NIDA to investigate cannabinoid receptors as an alternative toward treatment for opioid use disorder. (OHSU/Christine Torres Hicks)
